Founders
Dr. Panagiota Kasioumi
MSc, PhD Biologist,
MSc(c) Pharmaceutical Biosciences and Drug Development
"The integration of lived experience into scientific knowledge is a key factor in developing a comprehensive approach to pharmacovigilance."
Maria Karantza
BSc in Biochemistry,
MSc in Drug Discovery and Pharmaceutical Management
"Clinical trials mark the transition from controlled research to real-world clinical practice. In that context, systematic pharmacovigilance is essential for ensuring patient safety."
Research Associates
Alexander Eleftheriou
MD, BSc in Biomedical Sciences
"Confusion between a drug's side effects and the symptoms of a possible underlying condition is a common occurrence and can ultimately work to the patient's detriment, leading to misdiagnosis or delays in proper treatment."
Iliana Georgara Kitsou
DVM, MSc (candidate) in Pharmaceutical Biosciences & Drug Development
“Pharmacovigilance is the science that gives a voice to safety; it is our commitment to ensuring that every treatment remains beneficial throughout its entire lifecycle.”
Nikolaos Stefanos Bastas
BSc in Nursing, Researcher in Health Psychology and Public Health
“Drug safety is the cornerstone of therapeutic trust.”
Ioannis Papachristos
MEng, Biomedical Engineer, University of Ioannina; PhD candidate in Computational NeuroRadiology, University of Ioannina/Harvard; Science Communication Expert, EU
“Knowledge about medicines is not merely a science; it is a power that transforms every piece of information into a shield of protection, every observation into timely intervention, and every person into an active guardian of their own life.”
Dr. Sofia Gogou
PhD, MSc, MSc, Registered Nurse
"In my daily work with patients as a nurse, I have observed that the use of medications, while medically necessary, can carry risks such as side effects, dependence, and withdrawal symptoms."
Christos Efthymiadis
MSc in Computer Science and Engineering
"Through modern digital solutions, information technology supports education and a proper understanding of drug safety."
Marilina Mastrogianni
BSc in Applied Mathematics
, MSc in New Drug Development
“What we see in practice is that the same medication does not always produce the same result. Changes in dosage affect its safety profile, which is shaped by how it is used and not just by the medication itself.”
Panagiotis Ferentinos
MD
“An adverse reaction is not a ‘minor’ issue.
It’s information that could protect thousands of people.
Don’t ignore it. Report it.”
Scientific Advisors
Dr. Kalliroi Ziavrou
B.S., M.S., Ph.D. in Chemical Toxicology
Dr. Panagiotis Lekkas
DVM, MSc, PhD
"The rational use of pharmaceuticals requires evidence-based scientific knowledge, an understanding of pharmacodynamics and pharmacokinetics, as well as a strict commitment to the principles of bioethics and evidence-based medical practice."
Supporters
Cordia Health
